Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz

companiesTechCrunch AIJan 13, 2026

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

Impact: LowConfidence: MediumNovelty: Incremental
companiestechcrunch-ai

See the whole story

Read the original on TechCrunch AI

Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original source is authoritative.